Edwards Lifesciences Corp Net Income Loss

Quick Answer

Edwards Lifesciences Corp reported Net Income Loss of $1.07 billion for the year ending 2025.

  • Edwards Lifesciences Corp showed a decrease of -74.3% in Net Income Loss from 2024 to 2025.
  • This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Edwards Lifesciences Corp's Net Income Loss has declined by 28.6%.
  • Historical annual values: Fiscal year 2025: $1.07 billion | Fiscal year 2024: $4.17 billion | Fiscal year 2023: $1.40 billion | Fiscal year 2022: $1.52 billion | Fiscal year 2021: $1.50 billion.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: